Impact Biomedical (IBO) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $3.16, -7.20% vs the prior close of $3.40.
- Volume 29.00K shares, 2.0x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IBO slides 7.2% to $3.16, a 52-week low on 2.0x normal volume. Closed at $3.16, -7.20% vs the prior close of $3.40. Day range $2.62–$4.08, opened at $3.17.
IBO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — IBO slides 7.2% to $3.16, a 52-week low on 2.0x normal volume
- Closed at $3.16, -7.20% vs the prior close of $3.40. Day range $2.62–$4.08, opened at $3.17.
- Volume was 29.00K shares, 2.0x its 50-day average of 14.81K — unusually heavy trading.
- Price is -43.9% vs its 50-day average ($5.63) and -50.9% vs its 200-day average ($6.43).
- 52-week range $2.62–$10.51; today's close sits at 7% of that range, 69.9% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — IBO slides 14.5% to $3.40, a 52-week low, 3 down days in a row
- Closed at $3.40, -14.50% vs the prior close of $3.98. Day range $3.25–$3.85, opened at $3.59.
- Volume was 4.00K shares, 0.3x its 50-day average of 14.95K — lighter than usual.
- Price is -40.0% vs its 50-day average ($5.68) and -47.2% vs its 200-day average ($6.45).
- 52-week range $3.25–$10.51; today's close sits at 2% of that range, 67.6% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — IBO dips 1.2% to $3.98, a 52-week low
- Closed at $3.98, -1.24% vs the prior close of $4.03. Day range $3.84–$4.11, opened at $4.11.
- Volume was 9.40K shares, 0.6x its 50-day average of 14.80K.
- Price is -30.4% vs its 50-day average ($5.72) and -38.4% vs its 200-day average ($6.46).
- 52-week range $3.84–$10.51; today's close sits at 2% of that range, 62.1% below the 52-week high.
Oct 12, 2026 — IBO slides 5.2% to $4.03, a 52-week low
- Closed at $4.03, -5.18% vs the prior close of $4.25. Day range $4.00–$4.46, opened at $4.25.
- Volume was 7.40K shares, 0.5x its 50-day average of 14.67K — lighter than usual.
- Price is -29.9% vs its 50-day average ($5.75) and -37.7% vs its 200-day average ($6.47).
- 52-week range $4.00–$10.51; today's close sits at 0% of that range, 61.6% below the 52-week high.
Oct 9, 2026 — IBO jumps 3.4% to $4.25
- Closed at $4.25, +3.41% vs the prior close of $4.11. Day range $4.13–$4.39, opened at $4.13.
- Volume was 4.00K shares, 0.3x its 50-day average of 14.60K — lighter than usual.
- Price is -26.5% vs its 50-day average ($5.78) and -34.5% vs its 200-day average ($6.49).
- 52-week range $4.06–$10.51; today's close sits at 3% of that range, 59.5% below the 52-week high.
- SEC filings that day: 8-K.
Oct 8, 2026 — IBO slides 8.3% to $4.11, a 52-week low, 9 down days in a row
- Closed at $4.11, -8.26% vs the prior close of $4.48. Day range $4.06–$4.41, opened at $4.32.
- Volume was 17.60K shares, 1.2x its 50-day average of 14.27K.
- Price is -29.2% vs its 50-day average ($5.80) and -36.8% vs its 200-day average ($6.50).
- 52-week range $4.06–$10.51; today's close sits at 1% of that range, 60.9% below the 52-week high.
- That makes 9 straight losses.
Oct 7, 2026 — IBO slides 4.3% to $4.48, a 52-week low, 8 down days in a row
- Closed at $4.48, -4.27% vs the prior close of $4.68. Day range $4.36–$4.59, opened at $4.57.
- Volume was 10.70K shares, 0.8x its 50-day average of 14.08K.
- Price is -23.1% vs its 50-day average ($5.83) and -31.3% vs its 200-day average ($6.52).
- 52-week range $4.36–$10.51; today's close sits at 2% of that range, 57.4% below the 52-week high.
- That makes 8 straight losses.
Oct 6, 2026 — IBO slides 3.3% to $4.68, a 52-week low, 7 down days in a row
- Closed at $4.68, -3.31% vs the prior close of $4.84. Day range $4.43–$5.05, opened at $5.00.
- Volume was 21.20K shares, 1.6x its 50-day average of 13.68K.
- Price is -20.0% vs its 50-day average ($5.85) and -28.3% vs its 200-day average ($6.53).
- 52-week range $4.43–$10.51; today's close sits at 4% of that range, 55.5% below the 52-week high.
- That makes 7 straight losses.
Oct 5, 2026 — IBO slides 9.0% to $4.84, a 52-week low, 6 down days in a row
- Closed at $4.84, -9.02% vs the prior close of $5.32. Day range $4.84–$5.42, opened at $5.16.
- Volume was 16.70K shares, 1.2x its 50-day average of 13.36K.
- Price is -17.5% vs its 50-day average ($5.86) and -25.9% vs its 200-day average ($6.53).
- 52-week range $4.68–$10.51; today's close sits at 3% of that range, 53.9% below the 52-week high.
- That makes 6 straight losses.
Oct 2, 2026 — IBO dips 2.0% to $5.32, a 6-month low, 5 down days in a row
- Closed at $5.32, -2.03% vs the prior close of $5.43. Day range $5.26–$5.54, opened at $5.54.
- Volume was 11.60K shares, 0.9x its 50-day average of 13.18K.
- Price is -9.5% vs its 50-day average ($5.88) and -18.6% vs its 200-day average ($6.54).
- 52-week range $4.68–$10.51; today's close sits at 11% of that range, 49.4% below the 52-week high.
- That makes 5 straight losses.
IBO latest news & SEC filings
Every SEC filing by or about IBO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Sep 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Dss, Inc. sold 723 shares at $0.55 (≈$398) on Sep 22, 2026; now holds 589,701
- Dss, Inc. sold 27 shares at $6.95 (≈$188) on Sep 23, 2026; now holds 589,674
- Dss, Inc. sold 156 shares at $7.06 (≈$1.10K) on Sep 24, 2026; now holds 589,518
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 7, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $3.00K (prior year $7.00K) (-57.1% vs Jun 30, 2025)
- Net income: -$699.00K (prior year -$14.35M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.01 (prior year -$1.18) (loss narrowed vs Jun 30, 2025)
Things to know before you trade IBO
- How much it moves: over the last 20 sessions the average daily move was 4.67% (largest 14.8%). That is a volatile stock.
- Liquidity: about 13.68K shares (≈$43.21K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.16 vs a range of $2.62–$10.51 (7% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 79:1000 on Sep 23, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 8 sales; latest: Inc. Dss, sold 156 shares on Sep 24, 2026.
- Latest filings: 8-K Oct 9, 2026; 8-K Sep 17, 2026; 8-K Sep 15, 2026.
- Share count: 107.82M shares outstanding (Aug 4, 2026), +784.8% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Pharmaceutical Preparations.
IBO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 3.17 | 4.08 | 2.62 | 3.16 | 29.00K |
| Oct 14, 2026 | 3.59 | 3.85 | 3.25 | 3.40 | 4.00K |
| Oct 13, 2026 | 4.11 | 4.11 | 3.84 | 3.98 | 9.40K |
| Oct 12, 2026 | 4.25 | 4.46 | 4.00 | 4.03 | 7.40K |
| Oct 9, 2026 | 4.13 | 4.39 | 4.13 | 4.25 | 4.00K |
| Oct 8, 2026 | 4.32 | 4.41 | 4.06 | 4.11 | 17.60K |
| Oct 7, 2026 | 4.57 | 4.59 | 4.36 | 4.48 | 10.70K |
| Oct 6, 2026 | 5.00 | 5.05 | 4.43 | 4.68 | 21.20K |
| Oct 5, 2026 | 5.16 | 5.42 | 4.84 | 4.84 | 16.70K |
| Oct 2, 2026 | 5.54 | 5.54 | 5.26 | 5.32 | 11.60K |
| Oct 1, 2026 | 5.88 | 5.88 | 5.43 | 5.43 | 9.00K |
| Sep 30, 2026 | 5.48 | 5.75 | 5.48 | 5.60 | 3.90K |
| Sep 29, 2026 | 5.50 | 6.17 | 5.43 | 5.60 | 9.00K |
| Sep 28, 2026 | 5.69 | 6.02 | 5.59 | 5.61 | 9.30K |
| Sep 25, 2026 | 5.80 | 6.50 | 5.58 | 5.69 | 20.60K |
| Sep 24, 2026 | 6.86 | 6.86 | 5.51 | 5.65 | 23.40K |
| Sep 23, 2026 | 6.46 | 7.11 | 5.62 | 6.63 | 40.40K |
| Sep 22, 2026 | 7.03 | 7.03 | 6.68 | 6.68 | 12.23K |
| Sep 21, 2026 | 7.47 | 7.56 | 6.96 | 7.04 | 6.50K |
| Sep 18, 2026 | 7.23 | 7.47 | 6.96 | 7.47 | 7.70K |
About Impact Biomedical
Impact Biomedical (IBO) is listed on the NYSE and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WEST HENRIETTA, NY. State of incorporation: NV. Fiscal year ends December 31. SEC CIK 1834105.
IBO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jason Grady | Director | Mar 25, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Todd D Macko | Chief Financial Officer | Mar 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 24, 2026 | Inc. Dss, | Sale | 156 | $7.06 |
| Sep 23, 2026 | Inc. Dss, | Sale | 27 | $6.95 |
| Sep 22, 2026 | Inc. Dss, | Sale | 723 | $0.55 |
| Mar 27, 2026 | Todd D Macko | Sale | 43,400 | $0.56 |
| Mar 25, 2026 | Todd D Macko | Sale | 1,600 | $0.60 |
| Mar 23, 2026 | Jason Grady | Sale | 50,000 | $0.65 |
| May 27, 2025 | Inc. Dss, | Sale | 45,400 | $0.54 |
| May 22, 2025 | Inc. Dss, | Sale | 115,600 | $0.55 |
IBO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $32.00K | $-11.84M | -0.38 | $-1.89M |
| Dec 31, 2024 | — | $-24.71M | -2.30 | $-2.85M |
| Dec 31, 2023 | — | $-4.34M | -0.07 | $-2.85M |
| Dec 31, 2022 | $50.00K | $-7.25M | -0.10 | $-2.24M |
Latest balance sheet: total assets $16.75M, total liabilities $2.73M, cash $20.00K (as of Jun 30, 2026).
IBO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on IBO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.